In what is at least the third recall of generic Lipitor in the past two years, The Federal Food and Drug Administration announced a Class II recall of the Ranbaxy Laboratories Ltd product.
Over 64,000 bottles of the medication that lowers cholesterol levels were recalled in the United States as a reaction to the discovery by a pharmacist of a 20-milligram tablet in a sealed bottle which was marked as containing just 10-milligram tablets.
A Class II recall means that there is only a slight chance that severe bad consequences or death will ensue due to the problem. Ranbaxy, located in India, did not comment on the recall announcement.
Ranbaxy is India’s largest drug manufacturer by revenue. In November 2012 the company recalled 480,000 bottles of atorvastatin calcium, the generic name for Lipitor’s active ingredient, due to the discovery of tiny particles of glass by the company.